(UroToday.com) At the risk stratification of non-muscle invasive bladder cancer (NMIBC) through genomics and immunobiology session at the 2021 AUA Drug Development in NMIBC From Scientific, Regulatory, Clinician, and Patient Perspectives virtual meeting, Dr. Manjiri Dighe discussed the role of radiology and radiomics in staging and risk stratification of NMIBC.